NPI: 1063657088 · YBOR CITY, FL 33605 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/04/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/04/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,842 | $3.33M |
| 2019 | 26,332 | $3.57M |
| 2020 | 24,221 | $3.33M |
| 2021 | 18,520 | $1.48M |
| 2022 | 9,162 | $910K |
| 2023 | 4,417 | $415K |
| 2024 | 875 | $72K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,393 | 1,612 | $4.18M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,724 | 2,015 | $4.05M |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,396 | 1,267 | $2.04M |
| A4657 | Syringe, with or without needle, each | 5,774 | 1,463 | $1.30M |
| J1756 | Injection, iron sucrose, 1 mg | 8,153 | 1,526 | $702K |
| 85041 | 1,316 | 787 | $189K | |
| 85048 | 1,309 | 786 | $189K | |
| 83970 | 822 | 531 | $115K | |
| 83540 | 502 | 318 | $68K | |
| 83550 | 500 | 315 | $67K | |
| 82728 | 476 | 298 | $64K | |
| 85045 | 317 | 213 | $48K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 359 | 102 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 175 | 130 | $33K |
| 82108 | 85 | 57 | $8K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 31 | 13 | $6K |
| G0008 | Administration of influenza virus vaccine | 19 | 16 | $3K |
| 90674 | 18 | 13 | $3K |